Clinical Features and Body Composition in Men with Hormone-Sensitive Metastatic Prostate Cancer: A Pilot Study Examining Differences by Race
Black men treated with frontline therapies for metastatic prostate cancer (MPC) show better clinical outcomes than non-Black men receiving similar treatments. Variations in body composition may contribute to these findings. However, preliminary data are required to support this concept. We conducted...
Saved in:
| Main Authors: | Patricia M. Sheean, Paula O’Connor, Cara Joyce, Vasilios Vasilopoulos, Ami Badami, Melinda Stolley |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Prostate Cancer |
| Online Access: | http://dx.doi.org/10.1155/2022/9242243 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prostate cancer in men under 50: the impact of race/ethnicity and family history
by: Lechuang Chen, et al.
Published: (2025-12-01) -
The Conundrum of Treating de novo metastatic Hormone-Sensitive Prostate Cancer
by: Tessa van Elst, et al.
Published: (2025-04-01) -
Novel hormonal agents in men with metastatic castration resistant prostate cancer and reduced performance status: Experiences of a specialized single center
by: Thomas Büttner, et al.
Published: (2024-12-01) -
Role of circulating tumor cell clusters in patients with metastatic hormone-sensitive prostate cancer receiving a gonadotropin-releasing hormone antagonist: A pilot study
by: Yuki Kohada, et al.
Published: (2023-04-01) -
The Rapidly Evolving Treatment Landscape of Metastatic Hormone-Sensitive Prostate Cancer
by: Eun-mi Yu, et al.
Published: (2024-09-01)